You are here

Incretin-based medication: current state and future developments

Thursday, 19 September 2019, 08:30 - 10:00, Joslin Hall

Chair: F. Giorgino, IT

M.A. Nauck, DE: Clinical properties and differences between GLP-1 agonists

M.H. Tschöp, DE: Future development in GLP-1 receptor agonist treatment

J.J. Holst, DK: Lessons learned from studies with hybrid incretin therapies